Imaging device stocks turned in another poor performance in 1998, according to the results of an industry survey by HealthCare Markets Group (formerly WDI HealthCare Markets Group) of Hilton Head, SC. Shares of companies in the firm's imaging devices
Imaging device stocks turned in another poor performance in 1998, according to the results of an industry survey by HealthCare Markets Group (formerly WDI HealthCare Markets Group) of Hilton Head, SC. Shares of companies in the firm's imaging devices segment fell 23% for the year, placing the segment at 34th out of 39 sectors. Overall, healthcare industry stocks climbed 1.9% for the year.
Imaging's performance last year follows a similarly bleak year in 1997 in the HealthCare Markets Group survey. The imaging devices segment fell 9% for the year, compared with an overall rise of 10% for healthcare stocks in general (SCAN 1/14/98). The imaging devices segment grew 4% in 1996.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.